Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 5/27/15 )$62.61
Total Net Assets (As of 4/30/15)$4.46B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 3/31/15)
1 Year42.40%
3 Year37.04%
5 Year26.97%
10 Year15.75%
Morningstar (As of 4/30/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

123 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Data as of 4/30/15. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Johnson & Johnson 3.13
Amgen Inc 2.89
Biogen Inc 2.70
Valeant Pharmaceuticals International Inc 2.66
AbbVie Inc 2.54
Actavis plc 2.51
Roche Holding AG 2.29
Sanofi 2.24
Celgene Corp 2.15
Boston Scientific Corp 1.93
TOTAL25.04

CHARACTERISTICS

Number of Holdings
Equity Issues

93
Market Capitalization
Weighted Average
Median

$59.13B
$30.03B
Portfolio Turnover Ratio
(1-year trailing)

38.61%
Price/Earnings Ratio
(1-year forward)

20.56
Price/Book Ratio
(1-year forward)

8.31
Earnings Growth Rate
(1-year forward)

11.97%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Dyax Corp
AbbVie Inc
Valeant Pharmaceuticals International Inc
Juno Therapeutics Inc
Omnicare Inc
DETRACTORS
OvaScience Inc
Biogen Inc
Aerie Pharmaceuticals Inc
Puma Biotechnology Inc
Mallinckrodt PLC

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 95.02 100.00
 
 
Financials 1.15 -
 
Consumer Staples 0.97 -
 
Energy 0.22 -
 
Cash & Equivalents 2.10 -
 
Restricted Cash 0.54 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 75.02 64.18
Non-U.S. Developed 21.40 35.82
Non-U.S. Emerging 0.94 -
Restricted Cash 0.54 -
Cash & Equivalents 2.10 -

REGIONS (%)

FUNDINDEX
North America 79.13 65.99
Europe 15.57 27.33
Africa/Mideast 1.72 1.18
Asia/Pacific Ex Japan 0.94 1.24
Cash & Equivalents 2.10 -
Restricted Cash 0.54 -

COUNTRIES (%)

FUNDINDEX
United States 75.02 64.19
Switzerland 5.00 10.65
Canada 4.11 1.82
United Kingdom 3.47 5.92
France 2.94 3.29
Israel 1.72 1.18
Denmark 1.69 2.80
Germany 1.31 4.06
Sweden 0.95 0.19
China 0.94 -
Netherlands 0.21 -
Cash & Equivalents 2.10 -
Restricted Cash 0.54 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 24.24 53.13
$50 Billion to $100 Billion 12.23 15.49
$10 Billion to $50 Billion 28.28 27.17
$5 Billion to $10 Billion 7.11 3.42
$1 Billion to $5 Billion 18.39 0.79
$500 Million to $1 Billion 3.25 -
$250 Million to $500 Million 0.22 -
Under $100 Million 4.24 -
N/A 2.04 -

TOP INDUSTRIES (%)

FUNDINDEX
Pharmaceuticals 37.76 56.75
Biotechnology 34.01 15.09
Health Care Equipment 8.37 10.46
Health Care Services 5.57 3.82
Health Care Distributors 2.28 2.88
Health Care Facilities 1.86 1.00
Managed Health Care 1.77 5.45
Health Care Technology 1.65 0.58
Life Sciences Tools & Services 1.22 2.85
Insurance Brokers 1.14 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.